Drug Security Forum

An Effective Strategy in Drug Provision

14 Jun , 14:30–16:00
‘Ensuring Drug Security’ Russian Pharmaceutical Forum
Pavilion G, conference hall G4

The demand for public financing of medicines and other health technologies always exceeds the resources available across health systems, regardless of the country’s level of development. The problem dictates the need to choose the most effective medicines from a clinical and economic point of view within a limited budget. The Health Technology Assessment System (HTA) is a tool that allows to do it in a transparent and rational manner. This procedure is recognized as a tool for rational use of healthcare system funds in many countries. It has been a mandatory requirement for including medicines in the public financing system in the Russian Federation since 2014. The financial efficiency system by optimizing the choice of medicines needs to be constantly improved, taking into account the specifics of new technologies. Sharing best practices, knowledge, pooling the accumulated experience in this field contributes to more rational use of health systems. How to ensure the financial availability of drug therapy today? What are the limitations of the current HTA model for medicines? What further steps are required to improve current approaches to establishing restrictive lists of medicines? What are the approaches to HTA and procurement of innovative medicines? How should HTA and drug pricing be linked? Which areas of HTA should be prioritized for international cooperation and exchange of experiences?

Vitaliy Omelyanovskiy, General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation

Melita Vujnovic, Representative, World Health Organization Office in the Russian Federation
Anton Kugach, Head of the Department of Organization of Drug Supply, Ministry of Health of the Republic of Belarus
Elena Maksimkina, Director, "Federal Center for Planning and Regulation of Medical Supply Circulation" of the Ministry of Health of the Russian Federation
Oleg Malakhov, Chairman of the Board of Directors, PRIMEKEY Group of Companies; member of the General Council, All-Russian public organization "Business Russia"
Nuria Musina, Director of Development, Health Technology Assessment Association
Thi Thu Thuy Nguyen, Dean, Pharmacy Faculty, Hong Bang International University

Front row participant
Alima Almadiyeva, Deputy Chairman of the Board, National Scientific Center for Health Development named after Salidat Kairbekova (online)